Will be very interesting to hear the feedback, if any, from management subsequent to the meeting.
The information I was able to find confirmed to me that AHZ has succeeded in getting CardioCel used by some of the best surgeons in Europe who will be presenting the 7 different case studies to their peers at the conference.
If these elite surgeons are already using CardioCel (and I will presume finding it advantageous to use CardioCel over other products) leading to their presence and participation in the meeting AHZ should meet with success in gaining repeat orders and also new orders from other surgeons in the field.
I found this interesting…..., page-34
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |